92 results on '"Salvarani, Carlo"'
Search Results
2. Reduced Graphene Oxide Electrolyte‐Gated Transistor Immunosensor with Highly Selective Multiparametric Detection of Anti‐Drug Antibodies
3. One‐year clinical experience on the use of Nintedanib in systemic sclerosis
4. Response to the comment by Koster et al on the article: VEXAS syndrome: a case series from a single‐center cohort of Italian patients with vasculitis
5. Exploring Gene Expression Profiles in Primary Central Nervous System Vasculitis
6. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis
7. VEXAS Syndrome: A Case Series From a Single‐Center Cohort of Italian Patients With Vasculitis
8. Sensing Inflammation Biomarkers with Electrolyte‐Gated Organic Electronic Transistors
9. Sensing Inflammation Biomarkers with Electrolyte-Gated Organic Electronic Transistors
10. Genetic Association of a Gain‐of‐Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet’s Disease
11. Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis
12. Susceptibility to COVID‐19 in Patients Treated With Antimalarials: A Population‐Based Study in Emilia‐Romagna, Northern Italy
13. Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study
14. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting
15. Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
16. Large‐Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?
17. Clinical Spectrum of Medium‐Sized Vessel Vasculitis
18. Incidence, Prevalence, and Survival of Biopsy‐Proven Giant Cell Arteritis in Northern Italy During a 26‐Year Period
19. Contrast-Enhanced Ultrasound of the Carotid Artery in Patients With Large Vessel Vasculitis: Correlation With Positron Emission Tomography Findings
20. Histopathologic Findings of Patients With Biopsy‐Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population‐Based Study
21. Whole exome sequencing identifies rare protein-coding variants in Behçet's disease
22. 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative
23. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey
24. Adult Primary Central Nervous System Vasculitis Treatment and Course: Analysis of One Hundred Sixty-Three Patients
25. Brief Report: Interleukin-6 as an Inflammatory Mediator and Target of Therapy in Chronic Periaortitis
26. 2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative
27. Is the nail psoriasis severity index reliable in the assessment of nail psoriasis by rheumatologists?
28. Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: Two subsets of giant cell arteritis
29. Primary central nervous system vasculitis presenting with intracranial hemorrhage
30. A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease
31. Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis
32. Primary central nervous system vasculitis: Is it a single disease?
33. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis
34. Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?
35. Serum interleukin-6 receptor in polymyalgia rheumatica: A potential marker of relapse/recurrence risk
36. Reply
37. Primary central nervous system vasculitis with prominent leptomeningeal enhancement: A subset with a benign outcome
38. Efficacy of tumor necrosis factor α blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment
39. Infliximab for the treatment of Neuro-Behçet's disease: A case series and review of the literature
40. Treatment of refractory polymyalgia rheumatica with etanercept: An open pilot study
41. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis
42. Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: A seventeen-year population-based study
43. Primary central nervous system vasculitis: analysis of 101 patients
44. Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: Results of a fifty-four–week study
45. Giant cell arteritis: Involvement of intracranial arteries
46. Interleukin-10 promoter polymorphisms in giant cell arteritis
47. Chronic periaortitis and HLA–DRB1*03: Another clue to an autoimmune origin
48. Positron emission tomography (PET): Evaluation of chronic periaortitis
49. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis
50. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective followup study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.